PANCREATIC CANCER, ADULT
Clinical trials for PANCREATIC CANCER, ADULT explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER, ADULT trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to boost pancreatic cancer surgery success
Disease control Not yet recruitingThis Phase 3 trial tests whether adding the targeted drug surufatinib to standard chemotherapy before surgery helps more patients with high-risk pancreatic cancer have their tumors completely removed. About 106 adults with resectable or borderline resectable pancreatic cancer wil…
Matched conditions: PANCREATIC CANCER, ADULT
Phase: PHASE3 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Promising new drug cocktail targets tough pancreatic cancer
Disease control Not yet recruitingThis phase 2 trial tests whether adding nimotuzumab, a targeted antibody, to standard chemotherapy can help people with high-risk pancreatic cancer that can still be surgically removed. About 156 participants will receive either the drug combo or a placebo before and after surger…
Matched conditions: PANCREATIC CANCER, ADULT
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC